Transcatheter Embolization and Occlusion Devices Market Size by Product Type, Application, End-Use Industry, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2034
Overview
The Transcatheter Embolization and Occlusion Devices Market size is valued at USD 8.37 Billion in 2025 and is forecasted to grow at a CAGR of 9.8% from 2026 to 2034, reaching nearly USD 19.41 Billion.
The Transcatheter Embolization and Occlusion devices market refers to medical devices used in minimally invasive procedures to block or reduce blood flow to specific areas of the body. These devices include embolic coils, liquid embolic agents, particle embolization agents, occlusion plugs and balloon occlusion catheters which are utilized in the treatment of conditions like tumors, aneurysms, arteriovenous malformations (AVMs) and uterine fibroids. The rising demand for these treatments the advantages they offer compared to traditional surgeries and growing healthcare expenditure have contributed to the market growth.
North America is leading region in the global Transcatheter Embolization and Occlusion Devices industry with a share of 40.2% in 2025. Asia Pacific is forecasted to have continuous growth in the period from 2026-2034.
Transcatheter Embolization and Occlusion Devices Market Growth Outlook
To know about the Research Methodology :- Request Free Sample Report
Transcatheter Embolization and Occlusion Devices Market Dynamics
Driving Forces in the Transcatheter Embolization and Occlusion Devices Market:
Invasive Procedures, Technological Advancements, Healthcare Expenditure, Aging Population and Reimbursement Policies
The transcatheter Embolization and Occlusion devices market growth is fueled by various factors such as increasing prevalence of diseases like tumors, aneurysms, AVMs and uterine fibroids drives the demand for these devices. Growing preference for minimally invasive procedures as they offer advantages such as reduced trauma, shorter hospital stays and faster recovery. Technological advancements in device design and imaging technologies contribute to the market growth by improving the effectiveness and safety of these devices.
Rise in healthcare expenditure globally supports better access to advanced medical technologies including transcatheter embolization and occlusion devices. The aging population with its higher susceptibility to certain conditions further drives market growth. Favorable reimbursement policies and insurance coverage encourage healthcare providers to adopt these devices and perform procedures. While these drivers collectively contribute to the market growth, it's important to consider regional variations and factors such as regulations and competition that influence the market dynamics.
Seizing Growth Opportunities: Expanding Indications, Emerging Markets, Technological Advancements, Collaborations, Patient Education and AI Integration
The Transcatheter Embolization and Occlusion Devices market embarks a range of opportunities for growth and advancement. Growing the indications for these devices to treat a wider range of conditions presents a significant opportunity. Emerging markets in regions like Asia Pacific, Latin America and Africa offer untapped potential for manufacturers to establish their presence. Technological advancements such as improved device design, enhanced imaging guidance and integrated therapeutic functionalities provide avenues for innovation. Collaborations and partnerships among healthcare providers, manufacturers and research institutions drives research and development efforts while expanding market reach. Educating patients and healthcare professionals about the benefits of minimally invasive treatments to stimulate demand. Integrating artificial intelligence and data analytics into device capabilities allows for precise planning, real-time guidance and personalized treatment approaches. By capitalizing on these opportunities through innovation, partnerships, market growth and technological integration, companies thrive in the market.
Transcatheter Embolization and Occlusion Devices Market Restraints and Challenges
The growth and development of the transcatheter embolization and occlusion devices market face several restraints and challenges. These include a stringent regulatory environment with complex approval processes and compliance requirements, limited reimbursement coverage and inadequate rates, high device costs that hinder accessibility, limited comprehensive clinical evidence supporting long-term efficacy and safety, complexity of procedures requiring specialized expertise, potential device-related complications and competition from alternative treatment modalities. Overcoming these challenges necessitates addressing regulatory requirements, improving reimbursement policies, generating robust clinical data, providing training and education for healthcare providers and fostering continuous innovation. By effectively navigating these restraints and challenges, the market unlocks its full potential for growth and advancement.
Transcatheter Embolization and Occlusion Devices Market Trends
The Transcatheter Embolization and Occlusion Devices Market has significant trends that shape its growth and direction. Increasing preference for minimally invasive procedures among patients and healthcare providers is driven by the advantages of reduced trauma and improved patient outcomes. Technological advancements in device design, delivery systems and imaging techniques are enhancing the efficacy and safety of these devices.
There is also a growing trend towards expanding the indications for these devices driven by improved understanding of disease pathology and clinical evidence. Emerging markets such as Asia Pacific and Latin America, are experiencing rising demand due to improving healthcare infrastructure and awareness of minimally invasive treatments. The integration of image-guided techniques and a focus on patient safety and outcomes are key trends. Collaboration among industry players and research institutions is increasing, fostering research and development efforts. Adapting to these trends and embracing innovation will enable stakeholders to harness the growth opportunities in the market.
Transcatheter Embolization and Occlusion Devices Market Segment Analysis
The Transcatheter Embolization and Occlusion Devices Market has the following segments which gives the details about market by Product Type, Application, End-Use Industry, Distribution Channel and Region.
By Product Type, the Transcatheter Embolization and Occlusion Devices Market is segmented into Embolization Coils, Embolization Particles, Liquid Embolics, Flow Diverter Devices and Accessories. Embolization coils are the largest segment of the market with share of 55%. This is due to the high efficacy and safety of embolization coils in a variety of applications. Embolization particles are the second largest segment of the market and are forecasted to grow at a faster rate than the embolization coils segment during the forecast period. This is due to the increasing demand for minimally invasive treatment options for cancer and other diseases. Liquid embolics are the third largest segment of the market and are forecast to grow at a steady rate during the forecast period. Other segments are in the same order.
By Application, the Transcatheter Embolization and Occlusion Devices Market is segmented into Peripheral Vascular Disease, Oncology, Neurology, Urology and Others. Peripheral vascular disease is the largest segment of the market with share of over 35%. This is due to the high prevalence of peripheral vascular disease worldwide. Oncology is the second largest segment of the market. This is due to the increasing incidence of cancer worldwide. Neurology is the third largest segment of the market and is forecasted to grow at a steady rate during the forecast period. Urology is the fourth largest segment of the market and is forecasted to grow at a rapid rate during the forecast period. This is due to the increasing demand for these devices in the treatment of urinary tract tumors and other disorders. Others include applications such as the treatment of varicose veins and the occlusion of arteriovenous malformations.
By End-Use Industry, the Transcatheter Embolization and Occlusion Devices Market is segmented as Hospitals, Ambulatory Surgical Centers and End users. Hospitals are the major end users of transcatheter embolization and occlusion devices with share of over 70%. This is due to the fact that hospitals are the primary providers of healthcare services in most countries. Ambulatory surgical centers are the second largest end users of transcatheter embolization and occlusion devices due to the increasing demand for minimally invasive procedures in ambulatory settings. Other end users include clinics and research laboratories.
The Market is analyzed within 5 regions: North America, Europe, Asia Pacific, Middle East & Africa and South America.
Transcatheter Embolization and Occlusion Devices Market Regional Insights
North America, South America, Europe, Asia-Pacific, Middle East and Africa and South America are the five geographic regions that provides complete analysis for the investment and future growth. The Market is led by North America market. Asia-Pacific is forecasted to be largest region for Market in the forecast period 2026-2034.
North America: North America is the largest region for Transcatheter Embolization and Occlusion Devices Market in 2022 with market share of over 40%. The region has strong market position which attributes to factors such as well-established healthcare infrastructure, high adoption of advanced medical technologies and a large patient population. The United States leads the North American market due to a high prevalence of target diseases and favorable reimbursement policies.
Europe: The Europe is the second largest region for Market with share of over 28% in the global market share. The market growth is driven by factors such as the increasing aging population, rising prevalence of cardiovascular diseases and growing demand for minimally invasive treatments. Germany, the United Kingdom, France and Italy are major contributors to the European market.
Asia Pacific: Asia Pacific is the third largest region for Transcatheter Embolization and Occlusion Devices Market with share of over 21% in the global market share. The Asia Pacific region is witnessing rapid market growth due to improving healthcare infrastructure, rising disposable incomes and increasing awareness about minimally invasive procedures. China and India are forecasted to drive market growth supported by large patient populations, expanding middle-class population and government initiatives to enhance healthcare access. Medical tourism in countries like Thailand and Malaysia is contributing to market growth.
Middle East & Africa: The South America is forecasted to be the fourth largest region for market. Factors such as improving healthcare infrastructure, increasing investments in the healthcare sector and a growing focus on advanced medical technologies are driving the demand for transcatheter embolization and occlusion devices. The United Arab Emirates, Saudi Arabia and South Africa are among the key markets in the region.
South America: The South America is the growing region for Transcatheter Embolization and Occlusion Devices Market. Factors such as the increasing prevalence of cardiovascular diseases, growing healthcare expenditure and improving healthcare infrastructure are driving market growth in this region. Brazil and Mexico are the key markets in South America.
Transcatheter Embolization and Occlusion Devices Market Recent Industry Developments
| Date | Company | Development | Impact |
|---|---|---|---|
| 15 January 2026 | Boston Scientific Corporation | Boston Scientific entered into a definitive agreement to acquire Penumbra, Inc. for approximately $14.5 billion to expand its vascular and neurovascular embolization and thrombectomy portfolios. | The acquisition significantly strengthens Boston Scientific's market presence in peripheral embolization and computer-assisted vacuum thrombectomy (CAVT) technologies. |
| 06 January 2025 | Stryker Corporation | Stryker announced a definitive agreement to acquire Inari Medical, Inc. for $80 per share in cash, representing a total equity value of approximately $4.9 billion. | This transaction accelerates Stryker's expansion into high-growth peripheral vascular disease and catheter-based mechanical occlusion therapies. |
| 25 June 2025 | Embolization, Inc. | Embolization, Inc. secured U.S. FDA 510(k) clearance for its Nitinol Enhanced Device (NED), introducing a polymer-based embolic coil for peripheral arterial and venous embolization. | The clearance brings the market's first non-metal embolic coil designed to minimize CT and MRI imaging artifacts while providing rapid vessel occlusion. |
| 01 May 2026 | Terumo Corporation | Terumo Neuro launched the WovenEndoBridge (WEB) 17 Aneurysm Embolization System in Japan following regulatory approval for intracranial aneurysm procedures. | The approval broadens intrasaccular embolization treatment options for smaller and shallow-basined aneurysms while improving procedural operability. |
| 01 April 2026 | Shape Memory Medical Inc. | Shape Memory Medical initiated patient enrollment in the FLAGSHIP first-in-human study evaluating its novel False Lumen Embolization (FLE) System for aortic dissection. | The clinical milestone advances high-volume shape-memory polymer scaffold technology tailored to achieve rapid false lumen thrombosis and prevent aortic growth. |
Transcatheter Embolization and Occlusion Devices Market Competitive Analysis
The transcatheter embolization and occlusion devices market is fiercely competitive with several prominent players striving to capture market share. Leading the pack is Medtronic plc, a global medical technology company offering a diverse portfolio of transcatheter embolization and occlusion devices, followed by Terumo Corporation, a Japanese multinational known for its wide range of products in this domain. Boston Scientific Corporation, Cook Medical Inc., Stryker Corporation, Johnson & Johnson and Merit Medical Systems, Inc. are also major contenders, each contributing their unique offerings to the market. These companies engage in intense competition by focusing on product innovation, technological advancements, competitive pricing, distribution network expansion and geographical presence. They employ strategies such as continuous research and development, strategic collaborations and acquisitions to maintain their competitive edge in the market.
Transcatheter Embolization and Occlusion Devices Market Scope: Inquire before buying
| Transcatheter Embolization and Occlusion Devices Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 8.37 Billion |
| Forecast Period 2026 to 2034 CAGR: | 9.8% | Market Size in 2034: | USD 19.41 Billion |
| Segments Covered: | by Product Type | Embolization Coils Embolization Particles Liquid Embolics Flow Diverter Devices Accessories |
|
| by Application | Peripheral Vascular Disease Oncology Neurology Urology Others |
||
| by End-Use Industry | Hospitals Ambulatory Surgical Centers End users Professional |
||
Transcatheter Embolization and Occlusion Devices Market Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key players in the Global Transcatheter Embolization and Occlusion Devices Market
The Transcatheter Embolization and Occlusion Devices involves the global industry for specialized medical tools used in minimally invasive procedures to block or reduce blood flow inside blood vessels.
| Company Name | Headquarters | Core Competencies |
| Medtronic plc | Dublin, Ireland | Embolization coils, vascular plugs, neurovascular devices and interventional therapies |
| Terumo Corporation | Tokyo, Japan | Embolization coils, vascular plugs, microcatheters and interventional devices |
| Boston Scientific Corporation | Marlborough, Massachusetts, USA | Embolization coils, liquid embolics, vascular plugs and interventional oncology devices |
| Cook Medical LLC | Bloomington, Indiana, USA | Embolization coils, vascular plugs, microcatheters and interventional radiology devices |
| Stryker Corporation | Kalamazoo, Michigan, USA | Neurovascular embolization coils, flow-diversion and neurovascular intervention |
| Johnson & Johnson | New Brunswick, New Jersey, USA | Neurovascular technologies, embolization and minimally invasive intervention |
| Abbott Laboratories | Abbott Park, Illinois, USA | Vascular and structural-heart occlusion devices and catheter-based intervention |
| Merit Medical Systems, Inc. | South Jordan, Utah, USA | Embolization coils, microspheres, vascular plugs and interventional devices |
| Penumbra, Inc. | Alameda, California, USA | Neurovascular embolization devices, coils and vascular intervention |
| Teleflex Incorporated | Wayne, Pennsylvania, USA | Interventional vascular devices, catheters and embolization technologies |
| Sirtex Medical Limited | North Sydney, Australia | Microspheres and transarterial radioembolization technologies |
| Cordis Corporation | Miami Lakes, Florida, USA | Interventional vascular devices, embolization coils and catheter-based therapies |
| Acandis GmbH | Pforzheim, Germany | Neurovascular intervention, embolization and thrombectomy devices |
| Balt Group | Montmorency, France | Embolization coils, flow diverters, liquid embolics and neurovascular devices |
| Kaneka Medix Corporation | Osaka, Japan | Embolization coils, vascular intervention and medical devices |
| Shape Memory Medical Inc. | Santa Clara, California, USA | Shape-memory polymer embolization and vascular occlusion devices |
| pfm medical AG | Cologne, Germany | Interventional radiology, embolization and vascular devices |
| Micro Interventional Devices, Inc. | Newtown, Pennsylvania, USA | Vascular closure and occlusion devices |
| Metactive Medical Inc. | San Diego, California, USA | Embolization technologies and minimally invasive vascular therapies |
| Inari Medical, Inc. | Irvine, California, USA | Catheter-based vascular intervention and thromboembolic therapies |
Frequently Asked Questions:
1) What is the estimated value of the Global Transcatheter Embolization and Occlusion Devices Market in 2022?
Ans. The Global market was estimated to be valued at USD 8.37 Billion in 2025.
2) What is the growth rate of the Global Transcatheter Embolization and Occlusion Devices Market?
Ans. The market growth rate at the global level is 9.8% CAGR with a forecasted value of USD 19.41 Billion by 2034.
3) Which region has the highest growing potential globally?
Ans. Asia Pacific region is forecasted to grow at a CAGR of 9.8% in the Transcatheter Embolization and Occlusion Devices Market at highest rate among all regions in the forecast period of 2026-2034.
4) How is Global Transcatheter Embolization and Occlusion Devices Market segmented by Application?
Ans. The Transcatheter Embolization and Occlusion Devices Market is segmented as – Peripheral Vascular Disease, Oncology, Neurology,Urology, Others
5) By End-Use Industry, how is Global Transcatheter Embolization and Occlusion Devices Market segmented?
Ans. The Transcatheter Embolization and Occlusion Devices Market is segmented as – Consumer Electronics, Gaming and Professional.
6) How are the top players in Global Transcatheter Embolization and Occlusion Devices Market?
Ans. The research and analysis on the report encompasses the key companies in the Transcatheter Embolization and Occlusion Devices industry are Boston Scientific Corporation, Cook Medical Inc., Stryker Corporation, Johnson & Johnson, and Merit Medical Systems, Inc.